Inari Medical Inc
NASDAQ:NARI
Inari Medical Inc
Revenue
Inari Medical Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Inari Medical Inc
NASDAQ:NARI
|
Revenue
$493.6m
|
CAGR 3-Years
52%
|
CAGR 5-Years
136%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Inari Medical Inc
Revenue Breakdown
Breakdown by Geography
Inari Medical Inc
Total Revenue:
493.6m
USD
|
United States:
469.9m
USD
|
International:
23.8m
USD
|
Breakdown by Segments
Inari Medical Inc
Total Revenue:
493.6m
USD
|
Vte:
476.3m
USD
|
Emerging Therapies:
17.4m
USD
|
See Also
What is Inari Medical Inc's Revenue?
Revenue
493.6m
USD
Based on the financial report for Dec 31, 2023, Inari Medical Inc's Revenue amounts to 493.6m USD.
What is Inari Medical Inc's Revenue growth rate?
Revenue CAGR 5Y
136%
Over the last year, the Revenue growth was 29%. The average annual Revenue growth rates for Inari Medical Inc have been 52% over the past three years , 136% over the past five years .